Evidence map›Paper›PMID 42714387›Full record

ArticleAntimicrobial agents and chemotherapy2026

Functional validation of the

Angana Mukherjee, Ashenafi Bahita Assefa, Christopher V Turlo, Lisa Checkley Needham, Douglas Shoue, Tarrick Qahash, Mahlet Belachew, Dagimawie Tadesse, Enirsie Kassie, Mulu Berihun and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Angana Mukherjee *Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0002-7080-494X
Ashenafi Bahita Assefa *Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Christopher V TurloDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Lisa Checkley NeedhamDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Douglas ShoueDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Tarrick QahashDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Mahlet BelachewEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Dagimawie TadesseCollege of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.
Enirsie KassieEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Mulu BerihunEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Bokretsion G BrhaneEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Jonathan B ParrInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Michael T FerdigInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
MAREE Consortium

Funding

National Institute of Allergy and Infectious Diseases R01AI177791
6 · The paper itself

Abstract

Recent genomic investigation in Ethiopia identified the first detection of the

Indexed as

AntimalarialsPlasmodium falciparumProtozoan ProteinsArtemisininsCRISPR-Cas SystemsDrug ResistanceEthiopiaHumansMalaria, FalciparumMutationAntimalarialsArtemisininsartenimolProtozoan Proteinsartemisinin resistanceCRISPR-Cas9Ethiopiakelch13 (K13) C580Yparasite genetic backgroundPlasmodium falciparumring-stage survival assay

Identifiers

PMID42714387
PMCPMC13688931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.